People · Operator

Isabelle N. Kopec

Named in public records as an officer, director or promoter · active 2009–2011 · Other Health Care

1
Companies
3
Filings
$17.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Advanced Icu Care, Inc.Other Health CareSeries A$17.8M$147.8M2009
Operator network

Isabelle N. Kopec at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Timothy B. Petersen · 5 companies · 1 sharedTimothy B. Peters…Mary Jo Gorman · 4 companies · 1 sharedMary Jo GormanC. Thomas Smith · 2 companies · 1 sharedC. Thomas SmithLouis Silverman · 2 companies · 1 sharedLouis SilvermanAndrea M. Clegg · 1 companies · 1 sharedAndrea M. CleggAndrea Thomas Clegg · 1 companies · 1 sharedAndrea Thomas Cle…Barbara N. Lubash · 1 companies · 1 sharedBarbara N. LubashDavid N. Schopp · 1 companies · 1 sharedDavid N. SchoppDoug N. Webb · 1 companies · 1 sharedDoug N. WebbJohn N. Reardon · 1 companies · 1 sharedJohn N. ReardonMichael N. Mikolajczyk · 1 companies · 1 sharedMichael N. Mikola…Tim N. Petersen · 1 companies · 1 sharedTim N. PetersenToby Thomas Thomas · 1 companies · 1 sharedToby Thomas ThomasAdvanced Icu Care, Inc. · $17.8M raisedAdvanced Icu Care, In…Isabelle N. KopecIK
Isabelle N. Kopec Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Isabelle N. Kopec on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Timothy B. Petersen15
Mary Jo Gorman14
Louis Silverman12
C. Thomas Smith12
Barbara N. Lubash11
Michael N. Mikolajczyk11
Toby Thomas Thomas11
Andrea Thomas Clegg11
Tim N. Petersen11
Doug N. Webb11
David N. Schopp11
Andrea M. Clegg11
John N. Reardon11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.